Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 151 - 175 of 352
CK19 Alternative Name Cytokeratin 19 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK19 IHC Disease Bladder chordoma, CK19+ fragments is a poor prognostic factor for breast cancer,
CK20 Alternative Name Cytokeratin 20 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK20 IHC Disease Mucinous ovarian tumors, intestinal adenocarcinoma, Merkel cell carcinomas, urothelial
CK5/6 Alternative Name Cytokeratin 5/6 and CK5. Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK20 IHC Disease Epithelioid mesothelioma, colonic, urothelial and Merckel cell carcinomaBasic
CK7 Alternative Name Cytokeratin 7 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK7 IHC Disease Adenocarcinoma of lung, breast, thyroid, endometrium, cervix, ovary, salivary gland,
CK903 (HMCK) Alternative Name CK903 (34betaE12) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CK903 IHC Disease Prostate cancerAlso called CK903, High molecular weight keratin relatively
CMV by IHC Alternative Name Cytomegalovirus Methodology Immunohistochemistry (IHC) Test Description Probes/Genes CMV IHC Disease CMV related conditionsIdentification of cytomegalovirus infection
C-Myc by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes C-Myc IHC Disease Burkitt lymphomas (BL), Diffuse Large Cell LymphomaIHC for c-MYC overexpression (>40%) is used to
Congo Red Methodology Special Stains Test Description Probes/Genes CONGO R SS Disease Systemic or localized amyloidosis, progression of multiple myeloma and other plasma cell dyscrasiasCongo red is a direct
D2-40 (Podoplanin) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes D240 IHC Disease Confirmation of lymphovascular invasion, Primary skin adnexal tumors, Chondrosarcoma, Seminoma,
Desmin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes DESMIN IHC Disease Identification of striated and smooth muscle cells and tumors52kDa cytoplasmic intermediate filament present
DOG-1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes DOG-1 IHC Disease Gastrointestinal stromal tumor (GIST)DOG-1, a 986 amino acid protein of unknown function, is expressed predominantly
E-Cadherin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ECADH IHC Disease Differentiation between lobular and ductal neoplasms of the breast, Diffuse type gastric adenocarcinoma,
EGFR and ALK-1 by IHC for NSCLC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes EGFR IHC and ALK-1 IHC Disease Non-small cell lung cancersImmunohistochemistry has been proposed as
EMA Alternative Name Epithelial Membrane Antigen Methodology Immunohistochemistry (IHC) Test Description Probes/Genes EMA IHC Disease Meningioma, some hematopoietic tumors and malignant mesothelioma, and
Factor VIII (VW) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes FVIII IHC Disease Common endothelial marker, vascular neoplasm, and blast cells in acute megakaryocytic leukemiaCytoplasmic
Factor XIIIa Methodology Immunohistochemistry (IHC) Test Description Probes/Genes FAC 13 IHC Disease Fibrohistiocytic proliferations, dermal dendrocytes, dermatofibroma or benign fibrous histiocytoma (FH),
GATA3 Alternative Name GATA binding protein 3 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes GATA3 IHC Disease Bladder and breast carcinomas, and some types of mesenchymal and
GCDFP-15 Alternative Name Gross Cystic Disease Fluid Protein Methodology Immunohistochemistry (IHC) Test Description Probes/Genes GCDFP IHC Disease Carcinomas of the salivary glands, sweat glands, and
GFAP Alternative Name Glial Fibrillary Acidic Protein Methodology Immunohistochemistry (IHC) Test Description Probes/Genes GFAP IHC Disease Central nervous system (CNS) tumors, and colonic schwannomaIntermediate
Giemsa Alternative Name Wright Giemsa Methodology Special Stains Test Description Probes/Genes GIEMSA SS Disease Staining the blood cells of hematopoietic tissues. It can be applied to all tissues if presence
Glycophorin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes GLYC A IHC Disease Erythroid precursors in bone marrow, AML-M6Glycophorins A and B are major sialoglycoproteins of the human
Glypican Methodology Immunohistochemistry (IHC) Test Description Probes/Genes GLYP3 IHC Disease Distinguish hepatocellular carcinoma from nonmalignant liver lesions and metastasis, Subtyping testicular
GMS (fungus) Alternative Name Grocott Methanamine Silver Methodology Special Stains Test Description Probes/Genes GMS SS Disease Outlines fungal organisms by staining polysaccharides in cell wallsGrocott-Gomori
Granzyme B Methodology Immunohistochemistry (IHC) Test Description Probes/Genes GRANZB IHC Disease T/NK-cell lymphomaEnzyme associated with cytotoxic T lymphocytes; induces apoptosis in target cells of
H. pylori Alternative Name Helicobacter Pylori Methodology Immunohistochemistry (IHC) Test Description Probes/Genes HPYLOR IHC Disease demonstrating Helicobacter pylori infected tissue. Kit may be used
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.